{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:13:07Z","timestamp":1788250387488,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STA 1685\/1-1"],"award-info":[{"award-number":["STA 1685\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["82DZL009B1"],"award-info":[{"award-number":["82DZL009B1"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jcf.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T18:17:48Z","timestamp":1710872268000},"page":"863-869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Elexacaftor\/tezacaftor\/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8636-9214","authenticated-orcid":false,"given":"Charlotte O.","family":"Pioch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4195-8584","authenticated-orcid":false,"given":"Niklas","family":"Ziegahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Allomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5466-1793","authenticated-orcid":false,"given":"Leonie M.","family":"Busack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra N.","family":"Schnorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apolline","family":"Tosolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9689-8691","authenticated-orcid":false,"given":"Bent R.","family":"Fuhlrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Zagkla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Othmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulfiya","family":"Syunyaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1666-8924","authenticated-orcid":false,"given":"Simon Y.","family":"Graeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrak","family":"Yoosefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Thee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9633-7764","authenticated-orcid":false,"given":"Eva","family":"Steinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jobst","family":"R\u00f6hmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-2199","authenticated-orcid":false,"given":"Marcus A.","family":"Mall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6941-8315","authenticated-orcid":false,"given":"Mirjam","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2024.03.003_bib0001","first-page":"49","article-title":"European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia","author":"Lucas","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.03.003_bib0002","first-page":"115","article-title":"Update on the use of nitric oxide as a noninvasive measure of airways inflammation","volume":"47","author":"Scadding","year":"2009","journal-title":"Rhinology"},{"key":"10.1016\/j.jcf.2024.03.003_bib0003","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2362.2007.01758.x","article-title":"Nasal nitric oxide in cystic fibrosis with and without humming","volume":"37","author":"Struben","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jcf.2024.03.003_bib0004","doi-asserted-by":"crossref","first-page":"e79141","DOI":"10.1371\/journal.pone.0079141","article-title":"Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers","volume":"8","author":"Michl","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2024.03.003_bib0005","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1183\/09031936.96.09122537","article-title":"Airway nitric oxide in asthmatic children and patients with cystic fibrosis","volume":"9","author":"Dotsch","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.03.003_bib0006","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamaoto.2013.4099","article-title":"Nasal nitric oxide levels and nasal polyposis in children and adolescents with cystic fibrosis","volume":"139","author":"de Winter-de Groot","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jcf.2024.03.003_bib0007","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/thorax.57.7.586","article-title":"Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance","volume":"57","author":"Narang","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2024.03.003_bib0008","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/(SICI)1096-9896(199803)184:3<323::AID-PATH2>3.0.CO;2-2","article-title":"Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis","volume":"184","author":"Meng","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.jcf.2024.03.003_bib0009","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2024.03.003_bib0010","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1164\/rccm.201910-1943SO","article-title":"Cystic fibrosis: emergence of highly effective targeted therapeutics and potential clinical implications","volume":"201","author":"Mall","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.03.003_bib0011","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2024.03.003_bib0012","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2024.03.003_bib0013","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11882-012-0250-y","article-title":"Pathogenesis and management of nasal polyposis in cystic fibrosis","volume":"12","author":"Mainz","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jcf.2024.03.003_bib0014","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1513\/AnnalsATS.202209-763OC","article-title":"Longitudinal magnetic resonance imaging detects onset and progression of chronic rhinosinusitis from infancy to school age in cystic fibrosis","volume":"20","author":"Wucherpfennig","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2024.03.003_bib0015","article-title":"Chronic rhinosinusitis in the era of CFTR modulator therapy","author":"Stone","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.03.003_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/lary.30642","article-title":"Upper airway disease in adults with cystic fibrosis in the era of CFTR modulators","author":"Uyttebroek","year":"2023","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jcf.2024.03.003_bib0017","doi-asserted-by":"crossref","unstructured":"Wucherpfennig L., Triphan S.M.F., Wege S., Kauczor H.U., Heussel C.P., Schmitt N., Wuennemann F., Mayer V.L., Sommerburg O., Mall M.A., Eichinger M., Wielputz M.O. Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor\/tezacaftor\/ivacaftor therapy in adults with cystic fibrosis. J Cyst Fibros 2022;21:1053\u201360.","DOI":"10.1016\/j.jcf.2022.03.011"},{"key":"10.1016\/j.jcf.2024.03.003_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235638","article-title":"The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients","volume":"15","author":"Gostelie","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2024.03.003_bib0019","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1164\/rccm.201507-1271LE","article-title":"Intestinal current measurements detect activation of mutant CFTR in patients with cystic fibrosis with the G551D mutation treated with ivacaftor","volume":"192","author":"Graeber","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.03.003_bib0020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.202110-2249OC","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on CFTR function in patients with cystic fibrosis and one or two F508del alleles","volume":"205","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.03.003_bib0021","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/S1569-1993(23)00417-4","article-title":"P042 Nasal nitric oxide increases in patients with cystic fibrosis treated with elexacaftor\/tezacaftor\/ivacaftor","volume":"22","author":"Pioch","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.03.003_bib0022","first-page":"61","article-title":"Nasal nitric oxide measurement in children for the diagnosis of primary ciliary dyskinesia: European Respiratory Society technical standard","author":"Beydon","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.03.003_bib0023","article-title":"S2-Konsensus-Leitlinie \"Diagnose der Mukoviszidose\"","author":"Naehrlich","year":"2013","journal-title":"AWMF"},{"key":"10.1016\/j.jcf.2024.03.003_bib0024","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.03.003_bib0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/rccm.201604-0893OC","article-title":"Comparison of lung clearance index and magnetic resonance imaging for assessment of lung disease in children with cystic fibrosis","volume":"195","author":"Stahl","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.03.003_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(23)00293-X","article-title":"Reanalysis of N(2)-lung clearance index and the comparison to SF(6)-lung clearance index and magnetic resonance imaging","author":"Steinke","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.03.003_bib0027","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1513\/AnnalsATS.202101-057OC","article-title":"Impact of cystic fibrosis transmembrane conductance regulator therapy on chronic rhinosinusitis and health status: deep learning CT analysis and patient-reported outcomes","volume":"19","author":"Beswick","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2024.03.003_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1161891","article-title":"Long-term effects of lumacaftor\/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging","volume":"14","author":"Wucherpfennig","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2024.03.003_bib0029","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jcf.2020.07.002","article-title":"Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis","volume":"20","author":"DiMango","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.03.003_bib0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1183\/09031936.99.13111499","article-title":"Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome","volume":"13","author":"Grasemann","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.03.003_bib0031","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcf.2022.03.002","article-title":"Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis","volume":"21","author":"Stapleton","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.03.003_bib0032","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202310-1836OC","article-title":"Pharmacological improvement of cftr function rescues airway epithelial homeostasis and host defense in children with cystic fibrosis","author":"Loske","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.03.003_bib0033","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.202201-0219OC","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on lung clearance index and magnetic resonance imaging in patients with cystic fibrosis and one or two F508del alleles","volume":"206","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.03.003_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.12.012","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy in children with cystic fibrosis - a comprehensive assessment using lung clearance index, spirometry, and functional and structural lung MRI","author":"Streibel","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.03.003_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1125853","article-title":"Early and sustained improvements of lung clearance index from two to sixteen weeks of elexacaftor\/tezacaftor\/ivacaftor therapy in patients with cystic fibrosis-a real world study","volume":"14","author":"Appelt","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2024.03.003_bib0036","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/aa61aa","article-title":"Exhaled and nasal nitric oxide in relation to lung function, blood cell counts and disease characteristics in cystic fibrosis","volume":"11","author":"Krantz","year":"2017","journal-title":"J Breath Res"},{"key":"10.1016\/j.jcf.2024.03.003_bib0037","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1378\/chest.117.4.1085","article-title":"Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype","volume":"117","author":"Thomas","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.03.003_bib0038","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/19458924211059606","article-title":"Endoscopic sinus surgery for cystic fibrosis: variables influencing sinonasal and pulmonary outcomes","volume":"36","author":"Ji","year":"2022","journal-title":"Am J Rhinol Allergy"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2024.03.003_bib0039","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1569-1993(13)00150-1","article-title":"Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis","volume":"12","author":"Aanaes","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.03.003_bib0040","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/coa.13751","article-title":"Effect of endoscopic sinus surgery on clinical outcomes in DeltaF508 cystic fibrosis patients","volume":"46","author":"Dadgostar","year":"2021","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jcf.2024.03.003_bib0041","first-page":"360","article-title":"Endoscopic sinus surgery in patients with cystic fibrosis: a systematic review and meta-analysis of pulmonary function","volume":"50","author":"Macdonald","year":"2012","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jcf.2024.03.003_bib0042","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2500\/ajr.2006.20.2915","article-title":"An assessment of sinus quality of life and pulmonary function in children with cystic fibrosis","volume":"20","author":"Friedman","year":"2006","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jcf.2024.03.003_bib0043","doi-asserted-by":"crossref","unstructured":"Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 2000;67:117\u201333.","DOI":"10.1159\/000029497"},{"key":"10.1016\/j.jcf.2024.03.003_bib0044","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1378\/chest.06-2635","article-title":"Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, Pseudomonas infection, and polyunsaturated fatty acids","volume":"131","author":"Keen","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.03.003_bib0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jcf.2015.09.008","article-title":"Cystic fibrosis in young children: a review of disease manifestation, progression, and response to early treatment","volume":"15","author":"VanDevanter","year":"2016","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:14:24Z","timestamp":1788246864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324000341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1569199324000341"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.03.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elexacaftor\/tezacaftor\/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}